Premium
Practical management of inflammatory bowel disease patients during the COVID ‐19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty
Author(s) -
Aysha AlAni,
Rentsch Clarissa,
Prentice Ralley,
Johnson Doug,
Bryant Robert V.,
Ward Mark G.,
Costello Samuel P.,
Lewindon Peter,
Ghaly Simon,
Connor Susan J.,
Begun Jakob,
Christensen Britt
Publication year - 2020
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.14889
Subject(s) - medicine , inflammatory bowel disease , pandemic , context (archaeology) , covid-19 , disease , intensive care medicine , inflammatory bowel diseases , immunology , infectious disease (medical specialty) , paleontology , biology
The COVID‐19 pandemic, caused by the novel coronavirus SARS‐CoV‐2, has emerged as a public health emergency and challenged healthcare systems globally. In a minority of patients, SARS‐CoV‐2 manifests with a severe acute respiratory illness and currently there are insufficient data regarding the virulence of COVID‐19 in inflammatory bowel disease patients taking immunosuppressive therapy. This review aims to summarise the current literature and provide guidance on the management of inflammatory bowel disease (IBD) patients in the context of the COVID‐19 pandemic in the Australasian setting.